{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:06:25Z","timestamp":1784696785526,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.conb.2026.103220","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:19:50Z","timestamp":1779797990000},"page":"103220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Do animal models represent the diversity of clinical Parkinson\u2019s disease?"],"prefix":"10.1016","volume":"99","author":[{"given":"Mariangela","family":"Massaro Cenere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Ledonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6700-7491","authenticated-orcid":false,"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2026.103220_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson\u2019s disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.conb.2026.103220_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease","volume":"9","author":"Gigu\u00e8re","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.conb.2026.103220_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.conb.2026.103220_bib4","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.3390\/ijms23094508","article-title":"Pathophysiological features of nigral dopaminergic neurons in animal models of Parkinson\u2019s disease","volume":"23","author":"Guatteo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.conb.2026.103220_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110668","article-title":"Impact of sex on neuroimmune contributions to Parkinson\u2019s disease","volume":"199","author":"Bourque","year":"2023","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.conb.2026.103220_bib6","article-title":"Common genetic variants associated with risk of Parkinson\u2019s disease in Non-European populations: a PROSPERO registered systematic review based on genome-wide association studies","volume":"1","author":"Claudino dos Santos","year":"2024","journal-title":"LabMed Disc"},{"key":"10.1016\/j.conb.2026.103220_sref7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/diagnostics12010112","article-title":"Parkinson\u2019s disease subtyping using clinical features and biomarkers: literature review and preliminary study of subtype clustering","volume":"12","author":"Lee","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.conb.2026.103220_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.conb.2026.103220_bib9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41380-023-01955-x","article-title":"Does treatment with autophagy-enhancers and\/or ROS-scavengers alleviate behavioral and neurochemical consequences of low-dose rotenone-induced mild mitochondrial dysfunction in mice?","volume":"28","author":"Damri","year":"2023","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.conb.2026.103220_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.conb.2026.103220_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/sleep\/30.4.413","article-title":"Interleukin-1\u03b2 mediates sleep alteration in rats with rotenone-induced parkinsonism","volume":"30","author":"Yi","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.conb.2026.103220_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbr.2003.12.021","article-title":"L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats","volume":"153","author":"Alam","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.conb.2026.103220_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fncel.2014.00383","article-title":"Olfactory impairment in the rotenone model of Parkinson\u2019s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation","volume":"8","author":"Rodrigues","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.conb.2026.103220_bib14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatr"},{"key":"10.1016\/j.conb.2026.103220_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.04.006","article-title":"The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson\u2019s disease","volume":"173","author":"Troshev","year":"2021","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.conb.2026.103220_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfz082","article-title":"Sex differences in rotenone sensitivity reflect the male-to-female ratio in human Parkinson\u2019s disease incidence","volume":"170","author":"De Miranda","year":"2019","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.conb.2026.103220_bib17","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1073\/pnas.1900406116","article-title":"Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson\u2019s disease","volume":"116","author":"Lee","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2026.103220_bib18","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes Up-regulation and aggregation of \u03b1-Synuclein in mice: paraquat and \u03b1-SYNUCLEIN","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2026.103220_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2202-10-88","article-title":"Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10","volume":"10","author":"Somayajulu-Ni\u0163u","year":"2009","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.conb.2026.103220_bib20","first-page":"1","article-title":"Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat","volume":"4","author":"Anselmi","year":"2018","journal-title":"npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.conb.2026.103220_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152437","article-title":"Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson\u2019s disease","volume":"436","author":"Ding","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.conb.2026.103220_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-4159.2006.03923.x","article-title":"Temporal effects of paraquat\/maneb on microglial activation and dopamine neuronal loss in older rats","volume":"98","author":"Saint-Pierre","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2026.103220_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2015.10.021","article-title":"The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat","volume":"311","author":"Tinakoua","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.conb.2026.103220_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neures.2016.09.007","article-title":"Lipopolysaccharide-induced functional and structural injury of the mitochondria in the nigrostriatal pathway","volume":"114","author":"Hunter","year":"2017","journal-title":"Neurosci Res"},{"key":"10.1016\/j.conb.2026.103220_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ijms19010012","article-title":"Galangin reduces the loss of dopaminergic neurons in an LPS-evoked model of Parkinson\u2019s disease in rats","volume":"19","author":"Chen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.conb.2026.103220_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.autneu.2013.04.012","article-title":"Alterations in TH- and ChAT-immunoreactive neurons in the DMV and gastric dysmotility in an LPS-induced PD rat model","volume":"177","author":"Zheng","year":"2013","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.conb.2026.103220_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pnpbp.2014.01.016","article-title":"Intranigral lipopolysaccharide induced anxiety and depression by altered BDNF mRNA expression in rat hippocampus","volume":"51","author":"Hritcu","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.conb.2026.103220_bib28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/mds.29432","article-title":"The Endotoxin Hypothesis of Parkinson\u2019s disease","volume":"38","author":"Brown","year":"2023","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2026.103220_sref29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neuro.2008.02.014","article-title":"Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits","volume":"29","author":"Liu","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.conb.2026.103220_bib30","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mds.25736","article-title":"Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease","volume":"29","author":"Kelly","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2026.103220_bib31","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11011-015-9698-5","article-title":"Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson\u2019s disease model","volume":"30","author":"Li","year":"2015","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.conb.2026.103220_bib32","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/cns.14180","article-title":"Synergistic effects of lipopolysaccharide and rotenone on dopamine neuronal damage in rats","volume":"29","author":"He","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.conb.2026.103220_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","article-title":"alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity","volume":"454","author":"Liu","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2026.103220_bib34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1523\/JNEUROSCI.1526-22.2022","article-title":"\u03b1-Synuclein pathology and reduced neurogenesis in the olfactory system affect olfaction in a mouse model of Parkinson\u2019s disease","volume":"43","author":"Martin-Lopez","year":"2023","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2026.103220_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2012.11.045","article-title":"Comparison of motor performance, brain biochemistry and histology of two A30P \u03b1-synuclein transgenic mouse strains","volume":"231","author":"Piltonen","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.conb.2026.103220_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson\u2019s disease \u03b1-Synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2026.103220_bib37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/0963689717742662","article-title":"An enriched environment ameliorates oxidative stress and olfactory dysfunction in Parkinson\u2019s disease with \u03b1-Synucleinopathy","volume":"27","author":"Wi","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.conb.2026.103220_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-019-0146-z","article-title":"Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy","volume":"8","author":"Rota","year":"2019","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.conb.2026.103220_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-021-00439-2","article-title":"Parkinson mice show functional and molecular changes in the gut long before motoric disease onset","volume":"16","author":"Gries","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.conb.2026.103220_bib40","doi-asserted-by":"crossref","first-page":"8435","DOI":"10.1007\/s12035-019-01682-x","article-title":"Early sociability and social memory impairment in the A53T mouse model of Parkinson\u2019s disease are ameliorated by chemogenetic modulation of Orexin Neuron activity","volume":"56","author":"Stanojlovic","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.conb.2026.103220_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/awz380","article-title":"\u03b1-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson\u2019s disease model","volume":"143","author":"Taguchi","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.conb.2026.103220_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","article-title":"Abrogating native \u03b1-Synuclein tetramers in mice causes a L-DOPA-Responsive motor syndrome closely resembling Parkinson\u2019s disease","volume":"100","author":"Nuber","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2026.103220_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41531-024-00662-w","article-title":"Generation of G51D and 3D mice reveals decreased \u03b1-synuclein tetramer-monomer ratios promote Parkinson\u2019s disease phenotypes","volume":"10","author":"Nuber","year":"2024","journal-title":"npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.conb.2026.103220_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2015.09.002","article-title":"Depressive-like phenotype induced by AAV-mediated overexpression of human \u03b1-synuclein in midbrain dopaminergic neurons","volume":"273","author":"Caudal","year":"2015","journal-title":"Exp Neurol"},{"issue":"Pt 2","key":"10.1016\/j.conb.2026.103220_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/brain\/aws358","article-title":"A progressive dopaminergic phenotype associated with neurotoxic conversion of \u03b1-synuclein in BAC-transgenic rats","volume":"136","author":"Nuber","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.conb.2026.103220_bib46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.29269","article-title":"Morpho-functional changes of nigral dopamine neurons in an \u03b1-Synuclein model of Parkinson\u2019s disease","volume":"38","author":"Ledonne","year":"2023","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2026.103220_bib47","article-title":"TFE3-mediated neuroprotection: clearance of aggregated \u03b1-synuclein and accumulated mitochondria in the AAV-\u03b1-synuclein model of Parkinson\u2019s disease","volume":"12","author":"He","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.conb.2026.103220_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41398-022-01842-z","article-title":"Human \u03b1-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy","volume":"12","author":"Miquel-Rio","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.conb.2026.103220_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","article-title":"Neurodegeneration by \u03b1-synuclein-specific T cells in AAV-A53T-\u03b1-synuclein Parkinson\u2019s disease mice","volume":"101","author":"Karikari","year":"2022","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.conb.2026.103220_bib50","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2026.103220_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114781","article-title":"Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances","volume":"460","author":"Moceri","year":"2024","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.conb.2026.103220_bib52","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.28383","article-title":"Psychosis-like behavior and hyperdopaminergic dysregulation in human \u03b1-Synuclein BAC transgenic rats","volume":"36","author":"Polissidis","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2026.103220_sref53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13024-023-00683-8","article-title":"Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson\u2019s disease in rodent brains","volume":"18","author":"B\u00e9rard","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.conb.2026.103220_sref54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41531-024-00824-w","article-title":"Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson\u2019s disease overexpressing human alpha synuclein","volume":"10","author":"Massaro Cenere","year":"2024","journal-title":"npj Parkinson\u2019s Dis"},{"key":"10.1016\/j.conb.2026.103220_bib55","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1007\/s12035-024-04020-y","article-title":"The synergistic effect study of lipopolysaccharide (LPS) and A53T-\u03b1-Synuclein: intranasal LPS exposure on the A53T-\u03b1-Synuclein transgenic mouse model of Parkinson\u2019s disease","volume":"61","author":"He","year":"2024","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.conb.2026.103220_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2011.12.011","article-title":"Development and characterisation of a novel rat model of Parkinson\u2019s disease induced by sequential intranigral administration of AAV-\u03b1-synuclein and the pesticide, rotenone","volume":"203","author":"Mulcahy","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.conb.2026.103220_sref57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-Synuclein transmission initiates parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.conb.2026.103220_sref58","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awab242","article-title":"Dopamine-dependent early synaptic and motor dysfunctions induced by \u03b1-synuclein in the nigrostriatal circuit","volume":"144","author":"Tozzi","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.conb.2026.103220_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic \u03b1-synuclein species inducing mitochondrial damage and mitophagy in Parkinson\u2019s disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.conb.2026.103220_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106702","article-title":"\u03b1-Synuclein aggregation decreases cortico-amygdala connectivity and impairs social behavior in mice","volume":"202","author":"Zhou","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2026.103220_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh1403","article-title":"Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson\u2019s disease restoring striatal synaptic plasticity","volume":"9","author":"Marino","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.conb.2026.103220_bib62","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1093\/brain\/awaa283","article-title":"Propagated \u03b1-synucleinopathy recapitulates REM sleep behaviour disorder followed by parkinsonian phenotypes in mice","volume":"143","author":"Shen","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.conb.2026.103220_sref63","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2026.103220_bib64","doi-asserted-by":"crossref","first-page":"9242","DOI":"10.1038\/s41598-020-66201-8","article-title":"Deficits in olfactory sensitivity in a mouse model of Parkinson\u2019s disease revealed by plethysmography of odor-evoked sniffing","volume":"10","author":"Johnson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2026.103220_bib65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","article-title":"Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology","volume":"112","author":"Manfredsson","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2026.103220_bib66","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/mds.28512","article-title":"\u03b1-Synuclein spread from olfactory bulb causes hyposmia, anxiety, and memory loss in BAC-SNCA mice","volume":"36","author":"Uemura","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2026.103220_bib67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13311-021-01169-5","article-title":"Rapid induction of dopaminergic neuron loss accompanied by lewy body-like inclusions in A53T BAC-SNCA transgenic mice","volume":"19","author":"Okuda","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.conb.2026.103220_sref68","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3233\/JPD-223452","article-title":"A combined \u03b1-Synuclein\/Fibril (SynFib) model of parkinson-like synucleinopathy targeting the nigrostriatal dopamine system","volume":"12","author":"Bj\u00f6rklund","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.conb.2026.103220_bib69","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1523\/JNEUROSCI.4051-15.2017","article-title":"LRRK2 G2019S induces Anxiety\/depression-like behavior before the onset of motor dysfunction with 5-HT1AReceptor upregulation in mice","volume":"38","author":"Lim","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.conb.2026.103220_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.conb.2026.103220_bib71","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2015.02.031","article-title":"Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock in mice","volume":"78","author":"Yue","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2026.103220_bib72","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.cell.2022.06.038","article-title":"Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis","volume":"185","author":"Weindel","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.conb.2026.103220_bib73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2014.09.042","article-title":"A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2R1441G) transgenic mouse model of Parkinson\u2019s disease","volume":"583","author":"Dranka","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2026.103220_bib74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jnc.15240","article-title":"LRRK2 at the pre-synaptic site: a 16-years perspective","volume":"157","author":"Pischedda","year":"2021","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2026.103220_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2017.05.013","article-title":"The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson\u2019s disease in the mouse","volume":"105","author":"Giesert","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2026.103220_bib76","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2026.103220_bib77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","article-title":"Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb","volume":"235","author":"Glasl","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.conb.2026.103220_bib78","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00455-023-10567-0","article-title":"Pink1\u2212\/\u2212 rats demonstrate swallowing and gastrointestinal dysfunction in a model of prodromal Parkinson disease","volume":"38","author":"Krasko","year":"2023","journal-title":"Dysphagia"},{"key":"10.1016\/j.conb.2026.103220_bib79","doi-asserted-by":"crossref","first-page":"21418","DOI":"10.1074\/jbc.M413955200","article-title":"Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.conb.2026.103220_bib80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15548627.2018.1509818","article-title":"Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations","volume":"15","author":"Li","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.conb.2026.103220_bib81","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2026.103220_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113716","article-title":"Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson\u2019s disease","volume":"341","author":"Langley","year":"2021","journal-title":"Exp Neurol"},{"key":"10.1016\/j.conb.2026.103220_bib83","article-title":"Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson\u2019s disease","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.conb.2026.103220_bib84","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuro.2019.09.004","article-title":"MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson\u2019s disease","volume":"75","author":"Ghaisas","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.conb.2026.103220_sref85","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2026.103220_sref86","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1038\/s41467-024-53168-7","article-title":"Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits","volume":"15","author":"Laguna","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2026.103220_sref87","first-page":"1","article-title":"Effects of neuromelanin buildup in rodent nigral dopamine neurons: implications for sex-biased vulnerability in Parkinson's disease","volume":"223","author":"D\u2019Addario","year":"2026","journal-title":"Neurobiol Dis"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438826000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438826000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:45:02Z","timestamp":1784695502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438826000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":87,"alternative-id":["S0959438826000565"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2026.103220","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do animal models represent the diversity of clinical Parkinson\u2019s disease?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2026.103220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103220"}}